IRCT20200929048880N1招募中2 期
The effect of barley Savigh consumption on blood sugar in predibetic menopausal women, Gonabad-2020
Gonabad University of Medical Sciences0 个研究点目标入组 68 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 45 years 至 65 years（—）
- 性别
- Female
入选标准
- •Pre-diabetic women (fasting blood sugar between 100 and 125 or blood sugar two hours after a food between 140 and 199 mg / dL
- •Menopause(having amenorrhea for at least 12 months)
- •Age 65-45 years
- •No diabetes
- •Do not take anti-diabetic drugs
- •No cardiovascular, renal, hepatic, thyroid and hypertensive diseases
- •No history of smoking, drugs or alcohol
- •Literate to read and write
- •No history of grain allergy
- •Body mass index 19/8 to 29
排除标准
- •Incidence of diabetes during the study period
- •Need to start insulin therapy or blood sugar-lowering drugs during the study period
- •Occurrence of stressful events during the study period
- •Lack of regular consumption of barley savigh
- •Complication of the individual
- •Hospitalization during the intervention
- •Failure to complete the nutrition and physical activity questionnaire
- •Incidence of hypoglycemia during the intervention
研究者
相似试验
已完成
3 期
A clinical trial to study the effects of barley flour consumption on the preventive effect on diabetes and heart related illness.CTRI/2017/08/009292Sir Sunderlal Hospital Institute of Medical Sciences Banaras Hindu University Varanasi UPIndia205
已完成
Unknown
Effects of consumption of the test food on blood serotonin in healthy subjectsHealthy JapaneseJPRN-UMIN000053027ORTHOMEDICO Inc.11
已完成
不适用
Metabolic effects of barley intakeHealthy volunteerJPRN-UMIN000035802agano Prefecture Next-generation Health Care Industry Council20
已完成
不适用
Effects of barley intakeJPRN-UMIN000028940Shinshu University School of Medicine49
已完成
不适用
Effect of barley Intake on coronary heart disease risk factor, a randomized controlled trial.Women of aged 50 to 70 years, plasma total cholesterol of 220-280mg/dL, HbA1c of 5.5-6.5%, and without medication for hypertension, hyperlipidemia, and diabetes mellitus.JPRN-C000000081Department of Health Sciences Interdisciplinary Graduate School of medicine and Engineering, University of Ymanashi40